Objective We aimed to measure the mortality rate and excess general mortality as well as identify groups at high risk for mortality among a cohort of tuberculosis patients treated in Chennai Corporation clinics in south India. Methods In this retrospective cohort study we followed up 2674 patients (1800 males and 874 females) who were registered and treated under the DOTS strategy in Chennai Corporation clinics in 2000. The follow-up period from the date of start of treatment to either the date of interview, or death was 600 days. Findings The mortality rate among this cohort of tuberculosis patients was 60/1000 person-years. The excess general mortality expressed as standardized mortality ratio (SMR) was 6.1 (95% confidence interval (CI) = 5.4-6.9). Younger patients, men, patients with Category II disease, patients who defaulted on, or failed courses of treatment, and male smokers who were alcoholics, all had higher mortality ratios when compared to the rest of the cohort. Conclusion The excess mortality in this cohort was six times more than that in the general population. Young age, male sex, smearpositivity, treatment default, treatment failure and the combination of smoking and alcoholism were identified as risk factors for tuberculosis mortality. We suggest that mortality rate and excess mortality be routinely used as a monitoring tool for evaluating the efficiency of the national control programme.
Introduction
Tuberculosis (TB) is a major public health problem in India and most of the disease burden is due to premature mort t tality among TB patients. 1 Mortality is measured either as true rate (personttime rate) or as risk of death within a specific time period of followtup (casetfatality rate). The casetfatality rate is the more commonly used mortality measure of the two. However, casetfatality rates among TB patients reported in the literature range from 12% to 44% and are not comparable because they were measured as cumulative incidence for different followtup periods. [2] [3] [4] [5] [6] [7] [8] Risk factors such as smoking, alcoholism, irregular and incomplete antittuberculosis treatment as well as HIV infection are known to increase the mortality associated with TB. 2, 4, 5, 7, 9 WHO defines TB mortality as the number of TB cases dying during treatt t ment, regardless of the cause. 10 This definition, however, does not reflect the actual TB mortality rate because it includes deaths due to cotmorbidities and accidents, excludes deaths among treatment defaulters who have a high risk for mortality and presupposes that TB mortality does not occur after the completion of treatment. A better, though indirect, measure of mortality would be the computation of excess mortality (or standardized mortality ratio (SMR)) occurring among TB pat t tients and comparing it to the mortalt t ity among the standard population (or the estimated national population for a certain year). Since 1999, the Chennai Corporat t tion has been implementing the Revised National Tuberculosis Control Prot t gramme (RNTCP), applying the print t ciples of DOTS, in Chennai city through its network of clinics and hospitals. We measured the mortality rate and excess general mortality among TB patients registered with Chennai Corporation clinics in 2000 and identified the groups at high risk of mortality in this cohort.
Methods

Setting and study population
Chennai city consists of ten zones and each zone has a subtdistrict supervisory unit known as a Tuberculosis Unit covert t ing a population of 500 000. Our study population consisted of all TB patients aged 15 years, who were registered unt t der the RNTCP in 2000 in all Chennai Corporation clinics. We included deaths only among TB patients who were regist t tered and treated at the Corporation's clinics.
Definitions
In the RNTCP, treatment of patients is classified into three categories. Category I includes all new sputum smeartpositive and seriously ill smeartnegative and extratpulmonary patients. Category II includes all previously treated sputum smeartpositive patients, treatment after default, relapses and treatment failures. Category III includes sputum smeart negative patients, such as those with abnormalities on chest Xtray and extrat pulmonary patients.
Data collection
We collected data, such as the name, age, sex, residential address, category of treatment and date of registration of each patient from the RNTCP Tubert t culosis Register. A health worker visited the households of all registered patients at least once during the study period 
Follow-up
We retrospectively followedtup all pat t tients from the date of start of treatment in their respective RNTCP treatment centres, to either the date of interview (for the survivors) or the date of death (for the dead). Since all the survivors were followed up for a minimum period of 600 days (20 months), the followtup period for analysis for all survivors was set at 600 days and for those who were dead the followtup period was until the date of death within 600 days. The outcome "death" occurring within 600 days from start of treatment was used to measure the mortality in this cohort.
Data analysis
We measured mortality by age, sex, category of treatment and treatment outt t come in two ways: (1) excess mortality (or SMR) among TB patients compared to the mortality rate in the standard population (the standard population 
Results
Of the 2674 registered patients, 2422 (91%) survived the entire followtup period of 600 days from the date of start of treatment and 252 (9%) patients died during the followtup period. The cohort consisted of 1800 (67.3%) males and 874 (32.7%) females; and 1834 (68.6%) belonged to the younger age group of 15-44 years ( Table 1) . The standardized mortality ratios (SMR) for the study cohort are shown in Table 2 . Overall, the cohort had an SMR of 6.1 (95% confidence interval (CI) = 5.4-6.9). Among the three age groups, the 15-44 years age group had the hight t est SMR of 15.1 (95% CI = 12.5-17.9). Males had a higher SMR than females. Category II patients had a higher SMR, than those in Category I and Category III. Patients with treatment failure had a higher SMR than patients who defaulted on treatment. Male patients with a hist t tory of both smoking and alcoholism also had a high SMR.
The casetfatality rate for the cot t hort was 2.7% at 6 months 4.9% at 12 months and 9.4% at 20 months (Table 3) . At six months, patients aged 60 years had the highest casetfatality rate (6.9%). At 12 months, treatment failures had the highest casetfatality rate (22.2%) followed by patients 60 years (11.3%) and males who were both smokers and alcoholics (10.3%). At 20 months followtup, the casetfatality rate was highest among treatment failures (29.6%) followed by patients 60 years (19.4%), defaulters (17.8%) and males who were smokers and alcoholics (17.8%).
The risk of death increased with age, with adjusted hazard ratios for the 45-59 years and 60 years age groups being 1.6 (95% CI = 1.0-2.6) and 3.0 (95% CI = 1.7-5.3), respectively ( Table 4 ). The adjusted hazard ratios for treatment failures, defaulters and treatment completed were 7.7, 3.3 and 0.6, respectively, compared to cured patients. The adjusted hazard ratio for males who were smokers and alcoholics was 2.9 (95% CI = 1.8-4.7), compared to nontsmokers and nontalcoholics. The adjusted hazard ratios were signifit t cantly higher for the oldest age group, treatment defaulters, failures and male smokers who were also alcoholics.
The survival probabilities for 20 months followtup for age groups 15-44, 45-59 and 60 years were 93.1%, 87% and 80.6%, respectively (Fig. 1 ).
Discussion
Our analysis has shown that the mort t tality among this cohort was six times (SMR = 6.1) in excess of the mortalt t ity in the standard population. This is similar to the overall SMR of 8.3 for TB Research TB mortality in India C Kolappan et al.
patients reported from the Netherlands, using mortality rates among the general population as the standard 11 as was done in our study.
In this cohort, TB was a major cause of death among the 15-44 years age group than in those belonging to the 60 years age group. This was probably due to the very few competing causes for mortality in the younger group comt t pared to the older group. Male patients had a higher SMR than female patients reflecting the likelihood of majority of treatment defaults occurring among men 12 possibly due to additional risk factors such as smoking and alcoholism. Smeartpositive patients had a higher mortality than smeartnegative patients because smeartpositivity is related to severity of the disease.
The risk of mortality between the treatment and postttreatment periods was the same for all subgroups of patients, except male smokers who had a significantly higher risk during the treatment period than in the postt treatment period.
Our results have shown that the risk of mortality increased substantially among almost all subgroups from the second six months to the final eight a Subjects with incomplete data on behavioural factors, initial smear status, and treatment outcome of expired, transferred out and others were excluded (950 subjects) from this analysis. b Based on step-wise analysis, the hazard ratio was adjusted for patients with respect to age, treatment outcomes and behavioural factors. The remaining factors were found to be not significant by step-wise analysis method.
months -4.9% at the end of 12 months to 9.4% by the end of 20 months. Although it is difficult to ext t plain this increase in mortality after 12 months from the start of treatment, it is likely that these deaths were due to drugt sensitive or drugtresistant relapse cases. In our cohort, mortality continued to occur even after the completion of treatment emphasizing that the definit t tion of TB mortality should not be ret t stricted to the treatment period alone as this may result in underestimation of mortality.
While few studies have shown the association between smoking and TB and between alcoholism and TB, 7, 9, [13] [14] [15] none of these had simultaneously colt t lected data on both smoking and alcot t holism. We found that male patients who were both smokers and alcoholics had a higher SMR (10.7) than those who were either only smokers (3.7) or only alcoholics (6.0) demonstrating that smoking alone and alcoholism alone were not risk factors but smoking and alcoholism in combination became a risk factor. To draw a valid conclusion, however, about the effect of smoking and alcoholism separately on mortality among TB patients, a larger sample of patients with sufficient number of deaths in the smoking alone or alcoholism alone groups would be required.
We suspect that excess mortality rates may differ for cohorts selected from different areas or at different time points from the same area due to variations in the relative proportions of subgroups of patients with high SMRs, such as younger patients, smeartpositive patients, male smokers who are also alcoholics, irregularly treated patients and most importantly the efficiency of implement t tation of the treatment programme. We suggest that all these factors be considt t ered while interpreting mortality data.
Our study had two limitations. Alt t though the RNTCP treatment services were accessible to the entire population living in the Chennai Corporation area, the services were mostly used by people from the lower socioeconomic stratum. We would like to emphasize that in India, public sector health services, such as government hospitals and primary health centres, are mostly used by those from the lower socioeconomic stratum. Therefore, the findings from this study may be used to compare all public sect t tor health institutions implementing the RNTCP in India. 
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The second limitation was that we did not ascertain the human immunot t deficiency virus (HIV) status of the pat t tients. Interestingly, however, we found an indirect evidence of HIV prevalence in this cohort. HIV prevalence may be safely assumed to be very low in this populat t tion because of the very low casetfatality rate among the hightrisk age group of 15-44 years (1.7% and 3.4% for 6 and 12 months of followtup, respectively). It is known that mortality among TB patients in high HIVtprevalent regions occurs within the first few months of starting antittuberculosis treatment and is more among smeartnegative and extrat pulmonary TB patients. 2, 5, 16 In a region of low HIV prevalence, such as this study cohort, mortality is not restricted to any time period and occurs more among smeartpositive and pulmonary TB patients. Thus, we suggest that the pattern of mortality among TB patients be used as a proxy indicator for the level of HIV prevalence in a region.
We conclude that the mortality among this cohort of TB patients was six times higher than the mortality rate in the standard population. The excess mortality rate was very high among treatment failures, treatment defaulters, younger patients, smeartpositive patients (Categories I and II) and male smokers who were also alcoholics. Ensuring regut t larity of treatment by strictly adhering to the DOTS strategy would reduce mortality by minimizing treatment defaulters and failures. The SMR is a better measure of TB mortality than general mortality (in accordance with the current WHO definition) among TB patients during treatment. Our analysis proves that mortality rate is an important health index to monitor TB control prot t grammes. We suggest that mortality rate and excess mortality be routinely used, along with cure rates and conversion rates, as a monitoring tool for evaluating programme efficiency. O
Resumen
Mortalidad de los pacientes tuberculosos en Chennai (India)
Objetivo Decidimos medir la tasa de mortalidad y el exceso de mortalidad general, así como identificar los grupos con alto riesgo de mortalidad en una cohorte de enfermos tuberculosos tratados en consultorios de Chennai Corporation, en el sur de la India. Métodos En este estudio de cohortes retrospectivo seguimos a 2674 pacientes (1800 hombres y 874 mujeres) que se registraron y trataron en el marco de la estrategia DOTS en consultorios de Chennai Corporation en 2000. El periodo de seguimiento desde la fecha de comienzo del tratamiento hasta la fecha de la entrevista o la defunción fue de 600 días. Resultados La tasa de mortalidad en esa cohorte de pacientes con tuberculosis fue de 60/1000 años-persona. El exceso de mortalidad general expresado como razón de mortalidad normalizada (RMN) fue de 6,1 (intervalo de confianza (IC) del 95% = 5,4-6,9). Los pacientes más jóvenes, los hombres, los pacientes con enfermedad en la fase II, los pacientes perdidos o que dejaron el tratamiento y los fumadores varones alcohólicos presentaron todos ellos razones de mortalidad mayores en comparación con el resto de la cohorte. Conclusión El exceso de mortalidad en la cohorte considerada fue seis veces superior al de la población general. La edad temprana, el sexo masculino, la baciloscopia positiva, el abandono del tratamiento, el fracaso terapéutico y la combinación de tabaquismo y alcoholismo se revelaron como factores de riesgo de mortalidad por tuberculosis. Sugerimos que la tasa de mortalidad y el exceso de mortalidad se utilicen de forma sistemática como instrumentos de seguimiento para evaluar la eficiencia del programa nacional de control. 
